Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

A. Casadevall, David L. Goldman, M. Feldmesser

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalBulletin de l'Institut Pasteur
Volume95
Issue number4
DOIs
StatePublished - Oct 1997

Fingerprint

Communicable Diseases
Drug Therapy
Antibodies
Antibody Formation
Technology
Therapeutics
Infection
Renaissance

Keywords

  • Antibiotic resistance
  • HIV
  • Immunoglobulin
  • Opportunistic infection
  • Review
  • RSV
  • Septic shock
  • Therapeutics

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology

Cite this

Antibody-based therapies for infectious diseases : Renaissance for an abandoned arsenal? / Casadevall, A.; Goldman, David L.; Feldmesser, M.

In: Bulletin de l'Institut Pasteur, Vol. 95, No. 4, 10.1997, p. 247-257.

Research output: Contribution to journalArticle

@article{aa61979a21464c2a967eab5e740e0348,
title = "Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?",
abstract = "Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.",
keywords = "Antibiotic resistance, HIV, Immunoglobulin, Opportunistic infection, Review, RSV, Septic shock, Therapeutics",
author = "A. Casadevall and Goldman, {David L.} and M. Feldmesser",
year = "1997",
month = "10",
doi = "10.1016/S0020-2452(97)83532-5",
language = "English (US)",
volume = "95",
pages = "247--257",
journal = "Microbes and Infection",
issn = "1286-4579",
publisher = "Elsevier Masson SAS",
number = "4",

}

TY - JOUR

T1 - Antibody-based therapies for infectious diseases

T2 - Renaissance for an abandoned arsenal?

AU - Casadevall, A.

AU - Goldman, David L.

AU - Feldmesser, M.

PY - 1997/10

Y1 - 1997/10

N2 - Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

AB - Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

KW - Antibiotic resistance

KW - HIV

KW - Immunoglobulin

KW - Opportunistic infection

KW - Review

KW - RSV

KW - Septic shock

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=0031438485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031438485&partnerID=8YFLogxK

U2 - 10.1016/S0020-2452(97)83532-5

DO - 10.1016/S0020-2452(97)83532-5

M3 - Article

AN - SCOPUS:0031438485

VL - 95

SP - 247

EP - 257

JO - Microbes and Infection

JF - Microbes and Infection

SN - 1286-4579

IS - 4

ER -